Trial intelligence / Profile preview

Dexmedetomidine Versus Fentanyl on Time to Extubation in Patients With Morbid Obesity Undergoing Laparoscopic Sleeve Gastrectomy

NCT06052111Completed

Sponsor
Helwan University
Start
May 2021
Primary completion
May 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in class III obesity (2 arms), sponsored by Helwan University. Primary endpoint: Time to extubation. Started May 2021; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

class III obesity

Beyond the preview

Go deeper on NCT06052111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06052111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call